Patents by Inventor TAKAHIDE ABURATANI

TAKAHIDE ABURATANI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-GPRC5D ANTIBODY AND MOLECULE CONTAINING SAME
    Publication number: 20190367612
    Abstract: The present disclosure provides a novel antibody that binds to human GPRC5D; a molecule with human GPRC5D binding activity, which comprises the antibody; and an anti-tumor pharmaceutical composition comprising the antibody or the molecule as an active.
    Type: Application
    Filed: June 2, 2018
    Publication date: December 5, 2019
    Applicant: Daiichi Sankyo Company, Limited
    Inventors: Takashi CHAEN, Toshiaki OHTSUKA, Kenji IIDA, Kensuke NAKAMURA, Takahide ABURATANI, Junya ICHIKAWA, Shota KUDO, Chayne Lee PISCITELLI, Mario SANCHES
  • NOVEL BINDING PROTEINS FOR PCSK9
    Publication number: 20170173112
    Abstract: The present disclosure relates to novel lipocalin muteins which bind to PCSK9. The disclosure also provides corresponding nucleic acid molecules encoding lipocalin muteins and methods for producing lipocalin muteins as well as their encoding nucleic acid molecules.
    Type: Application
    Filed: February 28, 2017
    Publication date: June 22, 2017
    Applicant: Daiichi Sankyo Co., Ltd.
    Inventors: Gabriele MATSCHINER, Christine ROTHE, Andreas HOHLBAUM, Andrea ALLERSDORFER, Rachida Siham Bel AIBA, Marlon HINNER, Alexander WIEDENMANN, Bradley LUNDE, Shinji YAMAGUCHI, Takahide ABURATANI, Ryuji HASHIMOTO, Tohru TAKAHASHI, Chikako NAGASAKI, Futoshi NARA, Tomohiro NISHIZAWA
  • Nucleic acid molecules encoding muteins of human tear lipocalin which bind PCSK9
    Patent number: 9598476
    Abstract: The present disclosure relates to novel lipocalin muteins which bind to PCSK9. The disclosure also provides corresponding nucleic acid molecules encoding lipocalin muteins and methods for producing lipocalin muteins as well as their encoding nucleic acid molecules.
    Type: Grant
    Filed: August 28, 2015
    Date of Patent: March 21, 2017
    Assignee: Daiichi Sankyo Co., Ltd.
    Inventors: Gabriele Matschiner, Christine Rothe, Andreas Hohlbaum, Andrea Allersdorfer, Rachida Siham Bel Aiba, Marlon Hinner, Alexander Wiedenmann, Bradley Lunde, Shinji Yamaguchi, Takahide Aburatani, Ryuji Hashimoto, Tohru Takahashi, Chikako Nagasaki, Futoshi Nara, Tomohiro Nishizawa
  • NOVEL BINDING PROTEINS FOR PCSK9
    Publication number: 20160024161
    Abstract: The present disclosure relates to novel lipocalin muteins which bind to PCSK9. The disclosure also provides corresponding nucleic acid molecules encoding lipocalin muteins and methods for producing lipocalin muteins as well as their encoding nucleic acid molecules.
    Type: Application
    Filed: August 28, 2015
    Publication date: January 28, 2016
    Applicant: Daiichi Sankyo Co., Ltd.
    Inventors: Gabriele MATSCHINER, Christine Rothe, Andreas Hohlbaum, Andrea Allersdorfer, Rachida Siham Bel Aiba, Marlon Hinner, Alexander Wiedenmann, Bradley Lunde, Shinji Yamaguchi, Takahide Aburatani, Ryuji Hashimoto, Tohru Takahashi, Chikako Nagasaki, Futoshi Nara, Tomohiro Nishizawa
  • Human tear lipocalins which bind PCSK9 and methods of use thereof
    Patent number: 9150629
    Abstract: The present disclosure relates to novel lipocalin muteins which bind to PCSK9. The disclosure also provides corresponding nucleic acid molecules encoding lipocalin muteins and methods for producing lipocalin muteins as well as their encoding nucleic acid molecules.
    Type: Grant
    Filed: March 13, 2014
    Date of Patent: October 6, 2015
    Assignee: DAIICHI SANKYO CO., LTD.
    Inventors: Gabriele Matschiner, Christine Rothe, Andreas Hohlbaum, Andrea Allersdorfer, Rachida Siham Bel Aiba, Marlon Hinner, Alexander Wiedenmann, Bradley Lunde, Shinji Yamaguchi, Takahide Aburatani, Ryuji Hashimoto, Tohru Takahashi, Chikako Nagasaki, Futoshi Nara, Tomohiro Nishizawa
  • NOVEL BINDING PROTEINS FOR PCSK9
    Publication number: 20140288008
    Abstract: The present disclosure relates to novel lipocalin muteins which bind to PCSK9. The disclosure also provides corresponding nucleic acid molecules encoding lipocalin muteins and methods for producing lipocalin muteins as well as their encoding nucleic acid molecules.
    Type: Application
    Filed: March 13, 2014
    Publication date: September 25, 2014
    Applicants: Daiichi Sankyo Company, Limited, Pieris AG
    Inventors: GABRIELE MATSCHINER, CHRISTINE ROTHE, ANDREAS HOHLBAUM, ANDREA ALLERSDORFER, RACHIDA SIHAM BEL AIBA, MARLON HINNER, ALEXANDER WIEDENMANN, SHINJI YAMAGUCHI, TAKAHIDE ABURATANI, RYUJI HASHIMOTO, TOHRU TAKAHASHI, CHIKAKO NAGASAKI, FUTOSHI NARA, TOMOHIRO NISHIZAWA